Literature DB >> 27899498

Association of Visit-to-Visit Variability of Systolic Blood Pressure With Cardiovascular Disease and Mortality in Primary Care Chinese Patients With Type 2 Diabetes-A Retrospective Population-Based Cohort Study.

Eric Yuk Fai Wan1, Colman Siu Cheung Fung2, Esther Yee Tak Yu2, Daniel Yee Tak Fong3, Julie Yun Chen2, Cindy Lo Kuen Lam2.   

Abstract

OBJECTIVE: This study aimed to evaluate the impact of visit-to-visit variability (VVV) of systolic blood pressure (SBP) on cardiovascular disease (CVD) and mortality among primary care Chinese patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: A retrospective cohort study was conducted in 124,105 Chinese adult primary care patients with T2DM and without prior diagnosed CVD from August 2008 to December 2009. The VVV of SBP was evaluated using SDs of SBP over 24 months. The risks of CVD and all-cause mortality associated with variability in SBP were evaluated using Cox proportional hazards regression. Subgroup analysis was conducted by the stratification of age, sex, duration of diabetes, the presence of chronic kidney disease, baseline SBP and trend, and the number and class of antihypertensive drugs.
RESULTS: A positive linear relationship between the VVV of SBP and the first incidence of CVD and all-cause mortality was identified over a median follow-up time of 39.5 months. Patients with a low SD of SBP of <5 mmHg had the lowest risks of CVD and all-cause mortality, and patients with an SD of SBP of ≥10 mmHg had significantly higher risks. For every 1 SD increase in the SD of SBP, the risks of CVD, all-cause mortality, and the composite of both events increased by 2.9% (95% CI 2.4-3.4%), 4.0% (95% CI 3.5-4.6%), and 3.4% (95% CI 3.0-3.8%), respectively. A direct linear relationship was also observed in all selected subgroups.
CONCLUSIONS: SBP variability, irrespective of the mean SBP level, is a potential predictor for the development of CVD and all-cause mortality in patients with diabetes. In addition to monitoring BP targets for their patients with diabetes, clinicians should also remain vigilant about the visit-to-visit fluctuation of BP.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27899498     DOI: 10.2337/dc16-1617

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  17 in total

1.  Amelioration of arterial pressure lability: an unmissable target for diabetes management.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Hypertens Res       Date:  2017-03-16       Impact factor: 3.872

2.  Evaluation of Persistent Efficacy of Diabetes Remission and Decline of Cardiovascular Risk After Laparoscopic Sleeve Gastrectomy: a Preliminary 1-Year Study.

Authors:  Yu-Min Huang; Weu Wang; Shu-Chen Wei; Pei-Fen Lee; Yi-Chiang Hsu; Wan-Ling Tu; Hsin-Hung Chen
Journal:  Obes Surg       Date:  2022-07-23       Impact factor: 3.479

3.  Within-Visit Blood Pressure Variability and Cardiovascular Risk in ELSA-Brasil Study Participants.

Authors:  André Sant'Anna Zarife; Helena Fraga-Maia; José Geraldo Mill; Paulo Lotufo; Rosane Harter Griep; Maria de Jesus Mendes da Fonseca; Luciara Leite Brito; Maria da Conceição Almeida; Roque Aras; Sheila Maria Alvim Matos
Journal:  Arq Bras Cardiol       Date:  2022-09-02       Impact factor: 2.667

Review 4.  Variability of risk factors and diabetes complications.

Authors:  Antonio Ceriello; Francesco Prattichizzo
Journal:  Cardiovasc Diabetol       Date:  2021-05-07       Impact factor: 9.951

5.  Long-Term Variability of Blood Pressure, Cardiovascular Outcomes, and Mortality: The Look AHEAD Study.

Authors:  Arnaud D Kaze; Prasanna Santhanam; Sebhat Erqou; Matthew Yuyun; Alain G Bertoni; Rexford S Ahima; Justin B Echouffo-Tcheugui
Journal:  Am J Hypertens       Date:  2021-08-09       Impact factor: 3.080

6.  Prognostic importance of long-term SBP variability in high-risk hypertension.

Authors:  Rita Del Pinto; Davide Pietropaoli; Mirela Dobre; Claudio Ferri
Journal:  J Hypertens       Date:  2020-11       Impact factor: 4.776

7.  Ten-year risk prediction models of complications and mortality of Chinese patients with diabetes mellitus in primary care in Hong Kong: a study protocol.

Authors:  Eric Yuk Fai Wan; Esther Yee Tak Yu; Weng Yee Chin; Colman Siu Cheung Fung; Ruby Lai Ping Kwok; David Vai Kiong Chao; King Hong Chan; Eric Ming-Tung Hui; Wendy Wing Sze Tsui; Kathryn Choon Beng Tan; Daniel Yee Tak Fong; Cindy Lo Kuen Lam
Journal:  BMJ Open       Date:  2018-10-15       Impact factor: 2.692

8.  Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study.

Authors:  Zhe Bin Yu; Die Li; Xue Yu Chen; Pei Wen Zheng; Hong Bo Lin; Meng Ling Tang; Ming Juan Jin; Jian Bing Wang; Kun Chen
Journal:  Diabetes Metab J       Date:  2019-03-06       Impact factor: 5.376

9.  Peak lung function during young adulthood and future long-term blood pressure variability: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Yacob G Tedla; Yuichiro Yano; Bharat Thyagarajan; Ravi Kalhan; Anthony J Viera; Sharon Rosenberg; Philip Greenland; Mercedes R Carnethon
Journal:  Atherosclerosis       Date:  2018-06-15       Impact factor: 6.847

10.  Prognostic impact of systolic blood pressure variability in people with diabetes.

Authors:  Katy J L Bell; Lamiae Azizi; Peter M Nilsson; Andrew Hayen; Les Irwig; Carl J Östgren; Johan Sundröm
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.